Table of Contents
What changed
The supplied HY25 extraction is structurally incompatible with the HY24 and FY24 comparatives and the arithmetic deltas should not be read as operating performance:
- Current-period "revenue" is captured as Investment income of NZ$154 (per the source line "154 84 158", consistent with a fund-entity line item, not the Fonterra Co-op P&L that produced NZ$11,085m of revenue in HY24).
- PBT and NPAT are both reported as nil in the current extraction, versus NZ$904m and NZ$674m in HY24. The 100% decline reflects the entity shape of the extracted statements rather than a collapse at the underlying co-op.
- Total assets in the current extraction are NZ$535m with total liabilities also at NZ$535m, implying near-zero equity; HY24 showed total assets of NZ$18.2bn and equity of NZ$8.1bn. This is again consistent with a fund-entity balance sheet rather than the operating co-op's.
- The one unambiguous movement is the interim dividend, declared at 22.0 cps versus 15.0 cps, a 46.7% increase.
- Operating cash flow in the current extraction is a NZ$43m inflow versus a NZ$84m outflow in HY24, but the scale again suggests a different reporting boundary to the NZ$2,313m FY24 co-op figure.
What matters
- The comparability break is the dominant issue in this filing pack. Any calculation that uses the current NZ$154 "revenue" against HY24's NZ$11,085m, or current nil PBT against NZ$904m, is not an operating read. The "+1,289.2%" revenue growth figure in the calculation pass reflects a unit/entity mismatch (thousands vs millions, fund vs co-op) rather than a real trend.
- The only disclosure consistent with operational improvement is the commentary: the release notes Fonterra's "improved performance" has enabled a 22.0 cps fully-imputed interim dividend (up from 15.0 cps), volume growth "up 8.5%" helping to offset lower margins, and a NZ$103m (54%) increase in tax expense to NZ$297m — of which NZ$59m is attributable to a disclosed driver that is truncated in the excerpt.
- Without a reconciled continuing-operations P&L for HY25 in the structured data, the read-through to earnings quality, leverage direction, and return on capital cannot be quantified from the supplied pack.
Expectations
No quantitative FY25 guidance is present in the supplied extracts, and no forward-work or target disclosures were captured. The release text references an "Outlook for the remainder of FY25" section whose content is not in the excerpt set.
Seasonality context from FY24 shows the first half carried 48.6% of full-year revenue but 59.8% of full-year NPAT, so the HY24 base was front-loaded on profit despite being roughly level on revenue. Annualising the current-period NZ$154 figure against the NZ$22,822m FY24 base produces a ratio that is not interpretable for the reasons set out above. On the supplied data, the release does not support a quantified FY25 trajectory; it supports only the qualitative signal embedded in the 46.7% dividend lift.
Quality of result
Earnings durability cannot be assessed from the current-period extraction because PBT, NPAT and EBITDA are all either nil or not disclosed. The prior-period 21.0% effective tax rate is not a useful benchmark when the current period reports zero tax on zero pre-tax profit.
On cash, the move from a NZ$84m outflow to a NZ$43m inflow looks directionally positive, but with no capex, working-capital, receivables or inventory disclosure in the HY25 data, there is no way to judge how much of the improvement is operational versus timing. The HY24 base itself was unusual — operating cash flow was negative in the first half yet NZ$2,397m was generated in the implied second half — so half-year cash-flow comparability is weak even before the entity-shape question.
The dividend increase is the single data point that looks durable on its face, but the supplied pack does not let a reader test whether it is covered by free cash flow at the relevant entity, nor compute a payout ratio against the current period.
Unresolved
- Which entity's financials are actually represented in the current-period extraction, and how do they reconcile to the Fonterra Co-op numbers referenced in the commentary?
- What were HY25 continuing-operations revenue, EBIT, PBT, tax expense, NPAT and cash conversion at the co-op?
- What drove the NZ$103m (54%) jump in tax expense, and what is the NZ$59m component that the excerpt truncates?
- What is net debt and gross borrowings at period end, given HY24 gross borrowings of NZ$4,641m?
- What is the capex run-rate in HY25 versus the NZ$233m HY24 / NZ$577m FY24 base, and is the 22.0 cps dividend covered by free cash flow?
- What is said in the FY25 outlook section that is not captured in the supplied excerpt?
This briefing cannot assess the underlying operating performance of Fonterra's co-operative business in HY25 because the structured current-period data captures fund-entity line items rather than the consolidated co-op P&L, balance sheet and cash flow referenced in the release commentary.
Key metrics
| Metric | HY25 | HY24 | Change |
|---|---|---|---|
| Revenue | $154m | $11085m | -98.6% ↓ |
| Net profit after tax | $0m | $674m | -100.0% ↓ |
| Net cash inflow from operating activities | $43m | −$84m | +151.2% ↑ |
| Interim dividend per share | 22.0c | 15.0c | +46.7% ↑ |
| Profit before tax | $0m | $904m | -100.0% ↓ |
| Total assets | $535m | $18231m | -97.1% ↓ |
Reference: annolyse.ai/briefings/fcg-hy25
Analytical metrics
| Metric | HY25 | HY24 | Context |
|---|---|---|---|
| Effective tax rate | n/m (loss period) | 21.0% | current loss period |
| Capex | — | −$233.0m | — |
| Trade debtors | — | $69.0m | — |
| Gross borrowings | — | $4641.0m | — |
| HY24 share of FY24 revenue | 48.6% | — | Other half was 51.4% |
| HY24 share of FY24 NPAT | 59.8% | — | Other half was 40.2% |
| Profit from continuing operations | $0.0m | $714.0m | −$714.0m |
| Discontinued operation after tax | — | −$40.0m | — |
Reference: annolyse.ai/briefings/fcg-hy25
This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.